Advertisement
RMD vs SOLV
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMD is a Buy and SOLV is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
RMD’s FA Score shows that 0 FA rating(s) are green whileSOLV’s FA Score has 1 green FA rating(s).
- RMD’s FA Score: 0 green, 5 red.
- SOLV’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
RMD’s TA Score shows that 3 TA indicator(s) are bullish while SOLV’s TA Score has 3 bullish TA indicator(s).
- RMD’s TA Score: 3 bullish, 5 bearish.
- SOLV’s TA Score: 3 bullish, 4 bearish.
Price Growth
RMD (@Pharmaceuticals: Other) experienced а -0.61% price change this week, while SOLV (@Pharmaceuticals: Other) price change was +0.29% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.63%. For the same industry, the average monthly price growth was -0.63%, and the average quarterly price growth was +1.00%.
Reported Earning Dates
RMD is expected to report earnings on Jan 22, 2026.
SOLV is expected to report earnings on Feb 26, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-0.63% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| RMD | SOLV | RMD / SOLV | |
| Capitalization | 35.7B | 13.9B | 257% |
| EBITDA | 2B | 2.59B | 77% |
| Gain YTD | 7.583 | 21.375 | 35% |
| P/E Ratio | 25.02 | 9.21 | 272% |
| Revenue | 5.26B | 8.4B | 63% |
| Total Cash | 1.38B | 1.64B | 84% |
| Total Debt | 846M | 5.14B | 16% |
RMD | ||
|---|---|---|
OUTLOOK RATING 1..100 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 36 Fair valued | |
PROFIT vs RISK RATING 1..100 | 79 | |
SMR RATING 1..100 | 37 | |
PRICE GROWTH RATING 1..100 | 60 | |
P/E GROWTH RATING 1..100 | 75 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| RMD | SOLV | |
|---|---|---|
| RSI ODDS (%) | N/A | 3 days ago 40% |
| Stochastic ODDS (%) | 3 days ago 60% | 3 days ago 61% |
| Momentum ODDS (%) | 3 days ago 62% | 3 days ago 48% |
| MACD ODDS (%) | 3 days ago 68% | 3 days ago 60% |
| TrendWeek ODDS (%) | 3 days ago 58% | 3 days ago 67% |
| TrendMonth ODDS (%) | 3 days ago 54% | 3 days ago 61% |
| Advances ODDS (%) | 5 days ago 61% | 8 days ago 63% |
| Declines ODDS (%) | 3 days ago 61% | 3 days ago 56% |
| BollingerBands ODDS (%) | 3 days ago 61% | N/A |
| Aroon ODDS (%) | 3 days ago 55% | 3 days ago 72% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ITDD | 35.49 | 0.09 | +0.25% |
| iShares LifePath Target Date 2040 ETF | |||
| FBT | 215.07 | 0.47 | +0.22% |
| First Trust NYSE Arca Biotech ETF | |||
| FFDI | 30.30 | 0.02 | +0.07% |
| Fidelity Fundamental Developed International ETF | |||
| CPSN | 26.94 | 0.01 | +0.04% |
| Calamos S&P 500 Structured Alt Protection ETF - November | |||
| USCI | 78.89 | -0.07 | -0.09% |
| United States Commodity Index | |||
RMD and
Correlation & Price change
A.I.dvisor indicates that over the last year, RMD has been loosely correlated with SOLV. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RMD jumps, then SOLV could also see price increases.
| Ticker / NAME | Correlation To RMD | 1D Price Change % | ||
|---|---|---|---|---|
| RMD | 100% | -0.07% | ||
| SOLV - RMD | 52% Loosely correlated | -0.46% | ||
| BLCO - RMD | 46% Loosely correlated | +0.18% | ||
| NVST - RMD | 44% Loosely correlated | +0.59% | ||
| ALC - RMD | 42% Loosely correlated | +0.06% | ||
| COO - RMD | 40% Loosely correlated | -0.37% | ||
More | ||||
SOLV and
Correlation & Price change
A.I.dvisor indicates that over the last year, SOLV has been loosely correlated with NVST. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if SOLV jumps, then NVST could also see price increases.
| Ticker / NAME | Correlation To SOLV | 1D Price Change % | ||
|---|---|---|---|---|
| SOLV | 100% | -0.46% | ||
| NVST - SOLV | 54% Loosely correlated | +0.59% | ||
| RMD - SOLV | 52% Loosely correlated | -0.07% | ||
| XRAY - SOLV | 52% Loosely correlated | +1.26% | ||
| BAX - SOLV | 46% Loosely correlated | +0.95% | ||
| ALC - SOLV | 45% Loosely correlated | +0.06% | ||
More | ||||